dutasteride/tamsulosin

DRUG2 trials

Sponsors

GlaxoSmithKline

Conditions

Prostatic Hyperplasia

Phase 1

Bioequivalence - Duodart Against Avodart & Omnic

CompletedNCT01657851

GlaxoSmithKlineProstatic Hyperplasia

Start: 2012-08-23End: 2012-12-05Updated: 2017-06-20

Phase 4

Safety and Efficacy of 0.5mg Dutasteride and 0.4mg Tamsulosin Combination Once Daily for Six Months for Benign Prostatic Hyperplasia

TerminatedNCT01673490

GlaxoSmithKlineProstatic Hyperplasia

Start: 2012-06-29End: 2015-03-20Updated: 2018-08-20